A Study of QLS1209 in theTreatment of Patients With Advanced Solid Tumors
Clinical trial NCT06872580 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06872580
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-01
- Primary completion
- 2027-04-01
- Enrollment
- 149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.